Lynn Kirkpatrick
2023
In 2023, Lynn Kirkpatrick earned a total compensation of $508.6K as Chief Executive Officer at Ensysce Biosciences, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $93,800 |
|---|---|
| Salary | $404,875 |
| Other | $9,900 |
| Total | $508,575 |
Kirkpatrick received $404.9K in salary, accounting for 80% of the total pay in 2023.
Kirkpatrick also received $93.8K in option awards and $9.9K in other compensation.
Rankings
In 2023, Lynn Kirkpatrick's compensation ranked 2,021st out of 3,006 executives tracked by ExecPay. In other words, Kirkpatrick earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,021 out of 3,006 | 33rd |
Division Manufacturing | 1,151 out of 1,650 | 30th |
Major group Chemicals And Allied Products | 709 out of 918 | 23rd |
Industry group Drugs | 692 out of 881 | 22nd |
Industry Pharmaceutical Preparations | 496 out of 637 | 22nd |
Source: SEC filing on October 17, 2024.
Kirkpatrick's colleagues
We found two more compensation records of executives who worked with Lynn Kirkpatrick at Ensysce Biosciences in 2023.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021